Homburger with Novo Nordisk on new transaction
Homburger advised Novo Nordisk on its USD 11 billion acquisition of three manufacturing sites from Novo Holdings. The completion follows the finalization of Novo Holdings’ acquisition of Catalent. The three acquired sites specialized in the sterile filling of drugs are located in Anagni (Italy), Brussels (Belgium), and Bloomington IN (USA).
The advisors
Homburger advised Novo Nordisk on the transaction. The Homburger team comprised partners Andreas Müller and Anna Peter, associates Simone Schmid, Bianca Nedwed, Florian Bruggisser and paralegal Maria Braun (all corporate/M&A), counsel Allegra Arnold, junior associates Meret Horisberger and Harun Cetin (all regulatory), associate Jeremy Reichlin (employment) as well as partner Reto Heuberger, associates Juliette Buob and Philipp Stiegeler (all tax).
